drugset / Trial / NCT01438177

Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma

NCT01438177

NaSingle-groupOpen-labelTreatment

Summary

This pilot phase II trial studies how well giving bortezomib and cyclophosphamide together with chloroquine works in treating patients with relapsed or refractory multiple myeloma.

Timeline

Start
2011-10
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bortezomib Small molecule 1.3 mg/m2 Intravenous
Subject Chloroquine Small molecule 500 mg Oral
Subject Cyclophosphamide Other / unclassified 50 mg Oral

Indications